Rezultati

eNauka >  Results >  Molnupiravir compared to nirmatrelvir/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe. A matched-paired analysis from the EPICOVIDEHA registry
Title Molnupiravir compared to nirmatrelvir/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe. A matched-paired analysis from the EPICOVIDEHA registry
Authors: Salmanton-García, Jon; Marchesi, Francesco; Koehler, Philipp; Weinbergerová, Barbora; Čolović, Nataša  ; Falces-Romero, Iker; Buquicchio, Caterina; Farina, Francesca; van Praet, Jens; Biernat, Monika M.;
Issue Date: 2023
Publication: International Journal of Antimicrobial Agents
ISSN: 0924-8579 International Journal of Antimicrobial Agents Search Idenfier
Publisher: Amsterdam : Elsevier Science Publishers
Type: Article
Collation: vol. 62 br. 4 str. 106952-106952
DOI: 10.1016/j.ijantimicag.2023.106952
WoS-ID: 001259236700001
Scopus-ID: 2-s2.0-85170083215
PMID: 37582478
URI: https://enauka.gov.rs/handle/123456789/878362
URL: http://www.scopus.com/inward/record.url?eid=2-s2.0-85170083215&partnerID=MN8TOARS
https://www.sciencedirect.com/science/article/pii/S0924857923002315?via%3Dihub
Metadata source: (Preuzeto iz ORCID-a) Čolović, Nataša
M-category: 
21a+M21a+

14
SCOPUSTM
7
PubMed CentralTM
6
OpenCitations
12
WEB OF SCIENCETM
Alt metrika
Dimensions
Unpaywall

Rezultati na eNauka su zaštićeni autorskim pravima i sva prava su zadržana, osim ako nije drugačije naznačeno.